134 related articles for article (PubMed ID: 15551195)
1. Neuroimaging and 5-HT2C receptor polymorphism: a HMPAO-SPECT study in healthy male probands using mCPP-challenge of the 5-HT2C receptor.
Kühn KU; Joe AY; Meyer K; Reichmann K; Maier W; Rao ML; Reinhardt MJ; Biersack HJ; Quednow BB
Pharmacopsychiatry; 2004 Nov; 37(6):286-91. PubMed ID: 15551195
[TBL] [Abstract][Full Text] [Related]
2. Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.
Kühn KU; Quednow BB; Bagli M; Meyer K; Feuchtl A; Westheide J; Frahnert C; Maier W; Rao ML
Pharmacopsychiatry; 2002 Nov; 35(6):226-30. PubMed ID: 12518270
[TBL] [Abstract][Full Text] [Related]
3. Regional cerebral blood flow response to oral amphetamine challenge in healthy volunteers.
Devous MD; Trivedi MH; Rush AJ
J Nucl Med; 2001 Apr; 42(4):535-42. PubMed ID: 11337538
[TBL] [Abstract][Full Text] [Related]
4. Characterizing the effects of 5-HT(2C) receptor ligands on motor activity and feeding behaviour in 5-HT(2C) receptor knockout mice.
Fletcher PJ; Tampakeras M; Sinyard J; Slassi A; Isaac M; Higgins GA
Neuropharmacology; 2009 Sep; 57(3):259-67. PubMed ID: 19501602
[TBL] [Abstract][Full Text] [Related]
5. Modification of human 5-HT(2C) receptor function by Cys23Ser, an abundant, naturally occurring amino-acid substitution.
Okada M; Northup JK; Ozaki N; Russell JT; Linnoila M; Goldman D
Mol Psychiatry; 2004 Jan; 9(1):55-64. PubMed ID: 14699441
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological properties of the Cys23Ser single nucleotide polymorphism in human 5-HT2C receptor isoforms.
Fentress HM; Grinde E; Mazurkiewicz JE; Backstrom JR; Herrick-Davis K; Sanders-Bush E
Pharmacogenomics J; 2005; 5(4):244-54. PubMed ID: 15912142
[TBL] [Abstract][Full Text] [Related]
7. DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain.
Popp J; Leucht S; Heres S; Steimer W
Pharmacogenomics J; 2009 Feb; 9(1):71-7. PubMed ID: 18332898
[TBL] [Abstract][Full Text] [Related]
8. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
Leggio GM; Cathala A; Neny M; Rouge-Pont F; Drago F; Piazza PV; Spampinato U
J Neurochem; 2009 Oct; 111(2):614-23. PubMed ID: 19702657
[TBL] [Abstract][Full Text] [Related]
9. 5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats.
Kimura Y; Naitou Y; Wanibuchi F; Yamaguchi T
Eur J Pharmacol; 2008 Jul; 589(1-3):157-62. PubMed ID: 18582863
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of cerebellar 5-HT(2C) receptors in pilocarpine-induced epilepsy in rats: therapeutic role of Bacopa monnieri extract.
Krishnakumar A; Abraham PM; Paul J; Paulose CS
J Neurol Sci; 2009 Sep; 284(1-2):124-8. PubMed ID: 19439326
[TBL] [Abstract][Full Text] [Related]
11. Familial migraine with aura: association study with 5-HT1B/1D, 5-HT2C, and hSERT polymorphisms.
Racchi M; Leone M; Porrello E; Rigamonti A; Govoni S; Sironi M; Montomoli C; Bussone G
Headache; 2004 Apr; 44(4):311-7. PubMed ID: 15109354
[TBL] [Abstract][Full Text] [Related]
12. A Cys 23-Ser 23 substitution in the 5-HT(2C) receptor gene influences body weight regulation in females with seasonal affective disorder: an Austrian-Canadian collaborative study.
Praschak-Rieder N; Willeit M; Zill P; Winkler D; Thierry N; Konstantinidis A; Masellis M; Basile VS; Bondy B; Ackenheil M; Neumeister A; Kaplan AS; Kennedy JL; Kasper S; Levitan R
J Psychiatr Res; 2005 Nov; 39(6):561-7. PubMed ID: 16157158
[TBL] [Abstract][Full Text] [Related]
13. Serotonin systems upregulate the expression of hypothalamic NUCB2 via 5-HT2C receptors and induce anorexia via a leptin-independent pathway in mice.
Nonogaki K; Ohba Y; Sumii M; Oka Y
Biochem Biophys Res Commun; 2008 Jul; 372(1):186-90. PubMed ID: 18477467
[TBL] [Abstract][Full Text] [Related]
14. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
[TBL] [Abstract][Full Text] [Related]
15. Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C).
Lappalainen J; Zhang L; Dean M; Oz M; Ozaki N; Yu DH; Virkkunen M; Weight F; Linnoila M; Goldman D
Genomics; 1995 May; 27(2):274-9. PubMed ID: 7557992
[TBL] [Abstract][Full Text] [Related]
16. Activation of the brain 5-HT2C receptors causes hypolocomotion without anxiogenic-like cardiovascular adjustments in mice.
Stiedl O; Misane I; Koch M; Pattij T; Meyer M; Ogren SO
Neuropharmacology; 2007 Mar; 52(3):949-57. PubMed ID: 17141810
[TBL] [Abstract][Full Text] [Related]
17. 5-HT(2C) receptor activation inhibits appetitive and consummatory components of feeding and increases brain c-fos immunoreactivity in mice.
Somerville EM; Horwood JM; Lee MD; Kennett GA; Clifton PG
Eur J Neurosci; 2007 May; 25(10):3115-24. PubMed ID: 17561825
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of m-chlorophenylpiperazine after intravenous and oral administration in healthy male volunteers: implication for the pharmacodynamic profile.
Feuchtl A; Bagli M; Stephan R; Frahnert C; Kölsch H; Kühn KU; Rao ML
Pharmacopsychiatry; 2004 Jul; 37(4):180-8. PubMed ID: 15467976
[TBL] [Abstract][Full Text] [Related]
19. Thermogenic effect of YM348, a novel 5-HT2C-receptor agonist, in rats.
Hayashi A; Suzuki M; Sasamata M; Miyata K
J Pharm Pharmacol; 2004 Dec; 56(12):1551-6. PubMed ID: 15563762
[TBL] [Abstract][Full Text] [Related]
20. The relationship between regional cerebral blood flow and response to methylphenidate in children with attention-deficit hyperactivity disorder: comparison between non-responders to methylphenidate and responders.
Cho SC; Hwang JW; Kim BN; Lee HY; Kim HW; Lee JS; Shin MS; Lee DS
J Psychiatr Res; 2007 Sep; 41(6):459-65. PubMed ID: 16839567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
